FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084579 [Registered on: 11/04/2025] Trial Registered Prospectively
Last Modified On: 10/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To Evaluate The Efficacy Of Sharadipanchmuladdya Ghrut In Mutrashmari With Special Reference To Urolithiasis  
Scientific Title of Study   Randomised Controlled Clinical Study To Evaluate The Efficacy Of Sharadipanchmuladdya Ghrut In Mutrashmari With Special Reference To Urolithiasis  
Trial Acronym  no 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Abhilasha Shrishail Parit 
Designation  PG Scholar 
Affiliation  LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur Sangli  
Address  Shalyatantra OPD Of LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur

Sangli
MAHARASHTRA
415409
India 
Phone  9309823311  
Fax    
Email  abhilashaparit1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shubhangini Suresh Nagaralmath 
Designation  Associate Professor 
Affiliation  LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur 
Address  Shalyatantra OPD Of LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur

Sangli
MAHARASHTRA
415409
India 
Phone  7709677061  
Fax    
Email  shubhasn@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Abhilasha Shrishail Parit 
Designation  PG Scholar 
Affiliation  LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur 
Address  Shalyatantra OPD Of LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur

Sangli
MAHARASHTRA
415409
India 
Phone  9309823311  
Fax    
Email  abhilashaparit1998@gmail.com  
 
Source of Monetary or Material Support  
LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur Sangli Maharashtra 415409 INDIA 
 
Primary Sponsor  
Name  Dr Abhilasha Shrishail Parit 
Address  Shalyatantra OPD Of LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur Sangli Maharashtra 415409 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Abhilasha Shrishail Parit  LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur  Shalyatantra OPD Of LRP Ayurvedic Medical College And Hospital PG Institute And Research Centre Urun Islampur Sangli Maharashtra 415409
Sangli
MAHARASHTRA 
9309823311

abhilashaparit1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N23||Unspecified renal colic. Ayurveda Condition: ASMARI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Trikantak Ghrut, Reference: R.Vidyanath,Co-Author-K.Nishteswar Sahastrayog Samhita.Ghrutprakaran Adhyay 2,Trikantak Ghrut 22 ,Page no.77., Route: Oral, Dosage Form: Ghrita, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 21 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Sharadipanchmuladdya Ghrut, Reference: Bhavprakash Samhita Part 2 Choukhambha Sanskrit Prakashan ,8 Adhyay ,Shlok 82,Pg No. 390, Route: Oral, Dosage Form: Ghrita, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -Sharkara), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)Patient with clinical features and USG showing Mutrashmari of size upto 10mm will be taken for treatment.
2)The patient will be selected irrespective of gender, religion, occupation,marital status.
3)Patients of the age in between 20-60 years.
4)Patients with known case of mutrashmari
5)Grade 1 hydronephrosis
 
 
ExclusionCriteria 
Details  1)Patient with bleeding disorders – Immunoglobulin A,drug induced haematuria etc.
2)Malignant Disorders -Urethral malignancy or any suspected malignancy
3)Patients associated with disorders like Gout, Hyperthyroidism, Parathyroidism.
4)Patients with Immunocompromised disorders -Human immunodeficiency virus, Hepatitis B Surface Antigen, sexually transmitted disease
5)Case which required any other surgical intervention
6)Patient with mutrashmari with other urinary disorders like Chronic Urine retention, Pyelonephritis, BPH, glomerulonephritis, Nephropathy, Renal failure
7)Pregnant and lactating women
8)Patients with k/c/o hypertension and Diabetes Mellitus.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the efficacy of Sharadipanchmuladdya ghrut in Mutrashmari with special reference to Urolithiasis.  at 1st week,2nd week and on 3rd week 
 
Secondary Outcome  
Outcome  TimePoints 
1.To study in detail the literature about mutrashmari according to ayurvedic aspect.
2.To study urolithiasis in details according to modern aspect.
3.To Preparation of sharadipanchmuladdya ghrut.
4.To compare Sharadipanchmuladdya ghrut with Trikantak ghrut.
 
at 1st week, 2nd week & 3rd week 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   21/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Ayurveda has number of preparations, herbs and kalpas that are useful in management. Sharadipanchmuladdya ghrut is also one of them which is available affordable, and easy to administrate.
The aim of my study is Evaluation of the Efficacy of Sharadipanchmuladdya Ghrut in Mutrashmari with Special Reference to Urolithiasis.
This research investigates the efficacy of Sharadipanchmuladdya Ghrut, a traditional Ayurvedic formulation, in the treatment of Mutrashmari (urolithiasis). Urolithiasis, characterized by the formation of urinary stones, is a prevalent condition that can cause severe discomfort and complications.The study involved a sample size of 70 patients, all diagnosed with urolithiasis, to evaluate the therapeutic effects of Sharadipanchmuladdya Ghrut in alleviating symptoms, reducing stone size, and improving overall renal function. Patients were divided into treatment and control groups, with the treatment group receiving Sharadipanchmuladdya Ghrut for a specified duration.
 
Close